Literature DB >> 22279470

Is herbal medicine effective in the management of patients with chronic hepatitis C?

Hamid Kalantari1, Zahra Shahshahan.   

Abstract

Entities:  

Year:  2011        PMID: 22279470      PMCID: PMC3263115     

Source DB:  PubMed          Journal:  J Res Med Sci        ISSN: 1735-1995            Impact factor:   1.852


× No keyword cloud information.
Many thanks for providing us with the opportunity to discuss our article entitled: Effects of silybum marianum on patients with chronic hepatitis C virus (HCV).1 We were glad to receive Dr. Alavian's comment entitled “Herbal medicine and liver disease, for any conclusion we need more studies”. HCV is a major cause of liver-related morbidity and mortality.2 Ribavirin plus interferon combination therapy is presently considered as an optimal treatment for patients with chronic hepatitis C, but the recommended treatment regimen is concerned with considerable expense, adverse effects and poor efficacy in some patients. Although the popularity of silymarin has been increased in people with liver diseases,34 a few evidences with controversial results exist regarding the effect of silymarin on chronic HCV infection.

Comment

According to critical opinions of the author that the result of HCV RNA seroconverted to negative was very amazing, it should be mentioned that our sample size was small (55 cases) and the 16.4% negative rate could be due to chance. We calculated 95% confidence interval (CI) which was from 7.8% to 28.8% that means the 16.4% point estimate may be due to random error. All of the patients enrolled in our study were non cirrhotic and HIV negative. Their sonography reports were near normal. Because liver biopsy is an invasive method and many patients did not have any indication to do this, we assessed liver fibrosis including YKL-40 and Hyaluronic acid.5 The cause of death in one patient was not related to liver diseases or the prescribed herbal drug. Finally, we declare that our trial was open labeled (phase 2) and we recommend further researches especially blinded randomized placebo controlled clinical trials to clarify this issue.
  4 in total

1.  Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.

Authors:  Axel-M Gressner; Chun-Fang Gao; Olav-A Gressner
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

Review 2.  Silymarin treatment of viral hepatitis: a systematic review.

Authors:  K E Mayer; R P Myers; S S Lee
Journal:  J Viral Hepat       Date:  2005-11       Impact factor: 3.728

Review 3.  A review of plants used in the treatment of liver disease: part 1.

Authors:  S Luper
Journal:  Altern Med Rev       Date:  1998-12

4.  Effects of silybum marianum on patients with chronic hepatitis C.

Authors:  Hamid Kalantari; Zahra Shahshahan; Sayed Mehdi Hejazi; Taghi Ghafghazi; Vahid Sebghatolahi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.